Bryan Garnier - BICO GROUP (BICO.ST) BICO GROUP | UNDER REVIEW vs. BUY | Under Review

Report

Bryan Garnier

Dylan Van Haaften ...

Eric Yoo

BICO GROUP | UNDER REVIEW vs. BUY | Under Review

BICO GROUP | UNDER REVIEW vs. BUY | Under Review
• Q2 profit warning on murky outlook, TP, and Rating to Under Review.
• Disappointing Q2 results driven by account receivable write down…
• … however key worry is likely the capital sales outlook, rating to Under Review

18/07/2022 1 EN

Underlying

BICO GROUP

See profile

Provider

Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

See profile

Analysts

Dylan Van Haaften

Eric Yoo

Other Reports on these Companies

Bryan Garnier

BICO GROUP BUY | SEK169 BICO acquires Allegro 3D, and bolsters light-based 3D bioprinting capability

… º BICO is the industry leader in Bioprinting… We envisage light-based bioprinting to be the key differentiator amongst fierce competition… BICO to focus on smaller and strategic deals to bolster BICO’s core business… Reiterating Buy rating at a target price of SEK 169

May 9, 2022 May 9, 2022 1 EN

Bryan Garnier

BICO GROUP: BICO robust Q1 earnings after CFO resignation fallout | BUY | SEK169

BICO GROUP - BUY | SEK169 BICO robust Q1 earnings after CFO resignation fallout Strong organic growth confirms our hypothesis around the company’s trajectory toward profitability and high organic growth through operational excellence… All eyes are on positive EBITDA and free cash flow, more clarity upon investor call Reiterating Buy rating at a target price of SEK 169

May 4, 2022 May 4, 2022 1 EN

ONWARD: from brainGPT to ARC-BCI – fireside chat with the founders

Yesterday, we hosted an exclusive fireside chat at our Paris HQ with ONWARD's co-founders, Dr. Grégoire Courtine and Dr. Jocelyne Bloch, accompanied by institutional investors, to learn about the professional endeavours that led them to jump from researchers to entrepreneurs, with a special deep-di

20h / 19m 20h / 19m 1 EN

Mahaut Arnaud ... (+3)

Mahaut Arnaud
Paul de Froment
Thomas Mordelle

Avantium: joint-development progress in textiles

Yesterday, Avantium announced the successful development of a PEF-based spacer fabric in collaboration with partners Auping, Muller Textiles, Antex and Monosuisse. This breathable, cushioning 3D material marks a step forward for this partnership, ongoing since 2024, aiming to create PEF-based yarns

20h / 25m 20h / 25m 1 EN

Oscar Haffen Lamm

Oscar Haffen Lamm

Egetis: Article highlights Emcitate's broad efficacy in MCT8 deficiency

A recent publication in Nature Communications (Groeneweg, van Geest et al. 2025) highlights the broad therapeutic applicability of Emcitate across the heterogeneity of the MCT8 deficient target group and supporting its uniform treatment eligibility across a genetically diverse patient population. I

20h / 31m 20h / 31m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

BICO GROUP | UNDER REVIEW vs. BUY | Under Review

BICO GROUP BUY | SEK169 BICO acquires Allegro 3D, and bolsters light-based 3D bioprinting capability

BICO GROUP: BICO robust Q1 earnings after CFO resignation fallout | BUY | SEK169

ONWARD: from brainGPT to ARC-BCI – fireside chat with the founders

Avantium: joint-development progress in textiles

Egetis: Article highlights Emcitate's broad efficacy in MCT8 deficiency

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe